Eurofarma supports healthcare professionals with print and digital materials for safe return of patients to doctors’ offices in times of covid-19
Published in: August 18, 2020
and updated in: November 4, 2021
Listen to the text
Stop the audio
Sao Paulo, August 2020 – Eurofarma, reaffirming its belief in the appreciation of the medical class, has developed a series of communication materials so that healthcare professionals can engage with their patients and ensure a safe return to clinics and doctors’ offices.
This initiative came following a warning that chronic patients, who need frequent monitoring, stopped seeking care due to the insecurity brought about by the coronavirus. The actions included an online lecture by infectious disease specialist Bruno Scapellini, who gave important tips and addressed all the steps needed to ensure location asepsis, proper care with scrubs and personal protective equipment that should be used by healthcare professionals, as well as procedures for patient entry into the doctors’ offices. Leny Kyrillos, a speech therapist specializing in voice and commentator for CBN radio, also shared her knowledge with professionals about how to communicate assertively and convey safety to patients amidst the pandemic. One of the highlights of the presentation was how to express oneself properly using all the necessary equipment (mask, face shield, cap, etc.), items that impair interpersonal communication.
At www.eurofarma.com.br/voltapacientes, healthcare professionals can watch the webinar with Scapellini and Kyrillos and customize communication materials, with patient guidance and identification of their clinic or doctor’s office. There are 10 different templates, which can be customized with name and logo, all ready to print and free of charge.
So far, the company has allocated more than BRL 25 million for humanitarian aid and defined four different action fronts: donation of medicines; purchase and distribution of staple food kits; donation of personal protective equipment and hand sanitizer gel; and financial support to health institutions (Hospital São Paulo/Unifesp and Graac).
About Eurofarma Group
As the first multinational pharmaceutical company with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 313 products, 649 dosage forms, serves 25 medical specialties and covers 89 therapeutic classes, which represent 81% of prescriptions in the brand market.
The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported sales totaled BRL 5.6 billion in 2019 and the Group employs over 7,000 employees.
Eurofarma in social media
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarmalab | Twitter: @eurofarmaLab
This initiative came following a warning that chronic patients, who need frequent monitoring, stopped seeking care due to the insecurity brought about by the coronavirus. The actions included an online lecture by infectious disease specialist Bruno Scapellini, who gave important tips and addressed all the steps needed to ensure location asepsis, proper care with scrubs and personal protective equipment that should be used by healthcare professionals, as well as procedures for patient entry into the doctors’ offices. Leny Kyrillos, a speech therapist specializing in voice and commentator for CBN radio, also shared her knowledge with professionals about how to communicate assertively and convey safety to patients amidst the pandemic. One of the highlights of the presentation was how to express oneself properly using all the necessary equipment (mask, face shield, cap, etc.), items that impair interpersonal communication.
At www.eurofarma.com.br/voltapacientes, healthcare professionals can watch the webinar with Scapellini and Kyrillos and customize communication materials, with patient guidance and identification of their clinic or doctor’s office. There are 10 different templates, which can be customized with name and logo, all ready to print and free of charge.
So far, the company has allocated more than BRL 25 million for humanitarian aid and defined four different action fronts: donation of medicines; purchase and distribution of staple food kits; donation of personal protective equipment and hand sanitizer gel; and financial support to health institutions (Hospital São Paulo/Unifesp and Graac).
About Eurofarma Group
As the first multinational pharmaceutical company with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 313 products, 649 dosage forms, serves 25 medical specialties and covers 89 therapeutic classes, which represent 81% of prescriptions in the brand market.
The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported sales totaled BRL 5.6 billion in 2019 and the Group employs over 7,000 employees.
Eurofarma in social media
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarmalab | Twitter: @eurofarmaLab